Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Mcpab Updates topic
No spam. Unsubscribe anytime.
Medical Cannabis Policy Advisory Board recommends targeted rule changes and patient protections
Summary
The Medical Cannabis Policy Advisory Board reported votes supporting private‑sector nondiscrimination exploration, reduced caregiver background checks, limited pharmacy purchase‑limit exceptions and changes to product concealment rules; the board also recommended removing criminal consequences for patient combustion.
Get email alerts on the Mcpab Updates topic
No spam. Unsubscribe anytime.
The Medical Cannabis Policy Advisory Board (MCPAB) briefed the working group on several recommendations and internal votes intended to refine Utah’s medical cannabis program and reduce administrative burdens for patients.
Matthew Page and Desiree Hennessy, speaking for MCPAB, summarized board action across multiple meetings. The board voted 8–1 in favor of exploring private‑sector anti‑discrimination protections for medical cardholders, mirroring existing public‑employee protections while permitting employer exceptions tied to federal contract requirements. The board also discussed reducing caregiver/guardian background‑check requirements and favored replacing a full background check with a self‑attestation to lower cost burdens.
On pharmacy issues, MCPAB members requested a process allowing treating providers to request limited expansions of a patient’s 28‑day purchase limits for specific patients who demonstrably need more than the statutory cap. The board voted unanimously in September to permit such attestation‑based, time‑limited expansions with pharmacist re‑checks and renewal requirements.
MCPAB also recommended removing the statutory requirement that patients keep product in the opaque bag originally issued by a pharmacy; the proposal would still require products to be concealed but allow ordinary personal containers. The board discussed combustion (smoking) and recommended removing potential criminal penalties for patients who combust their medicine; the proposal received broad support among board members, with an expected dissent from law‑enforcement representatives.
Ending: MCPAB asked the working group and staff to consider drafting statutory or rule language to implement the board’s recommendations and to coordinate further stakeholder outreach before filing bills.
